Persistent antigen
Inflammatory cytokines T EX Are a Discrete T Cell Subset T cell exhaustion is a distinct differentiation state that can be distinguished from naive, effector, and memory T cells. Compared to effector (T E ) and memory (T MEM ) T cells, exhausted T cells (T EX ) display impaired effector functions (e.g., rapid production of effector cytokines, cytotoxicity) (Wherry and Kurachi, 2015) . T EX have limited proliferative potential, especially compared to some subsets of T MEM (e.g., T SCM and T CM ) and naive T cells (T N ). T EX also develop a distinct transcriptional program that is unlike T N , T E , or T MEM (Doering et al., 2012; Martinez et al., 2015; Paley et al., 2012) , a feature shared between chronic infections and cancer (Baitsch et al., 2011) . T EX confer only weak or temporary immune pressure on chronic infections or tumors, and this immunity is ultimately ineffective (Wherry and Kurachi, 2015) . T EX can be re-invigorated by blockade of PD-1 and other inhibitory receptors and immunoregulatory pathways (Barber et al., 2006; Wherry and Kurachi, 2015) . This re-invigoration demonstrates that at least a subset of T EX retains residual protective potential and has been translated into impressive clinical results in cancer (Page et al., 2014) . Exhaustion can develop in both CD4 + and CD8 + T cells, though CD8 + T cell exhaustion is better understood and is the focus of this Snapshot.
Origins of Exhaustion
Unlike other forms of T cell dysfunction (e.g., anergy), exhaustion is not induced at priming (Wherry and Kurachi, 2015) . Longitudinal analyses support the notion of gradual induction of dysfunction. For example, the transcriptional profi les of virus-specifi c CD8 + T cells during an acutely resolving versus developing chronic viral infection are largely similar at days 6 and 8 post-infection (p.i.). At day 15 p.i., these transcriptional programs diverge toward memory or exhaustion (Doering et al., 2012; Wherry and Kurachi, 2015) . Moreover, CD8 + T cells primed during a chronic infection can develop into functional T MEM if removed from the chronic infection at day 8 p.i., but not day 15 or 30 p.i. Brooks et al., 2006) . T EX and T MEM also both develop from the CD127 + KLRG1  "memory precursor" subset of T E , indicating a common developmental origin for T EX and T MEM .
Signals for the Development of T EX
While the development of T EX remains incompletely understood, persisting and likely continuous rather than intermittent antigen stimulation appears to be a key signal driving exhaustion. However, other types of signals are also likely important. These include: proinfl ammatory (e.g., IFN-/, IL-6, IL-27) and suppressive (e.g., IL-10, TGF-) cytokines, other regulatory leukocytes (e.g., regulatory T cells, immunoregulatory antigen presenting cells), and the tissue microenvironment (e.g., altered hypoxia, nutrients, pH) (Wherry and Kurachi, 2015) . Together with chronic TCR engagement, these signals drive elevated and sustained expression of multiple inhibitory receptors (e.g., PD-1, Lag-3, Tim-3, etc.), altered use of key transcription factors (e.g., T-bet, Eomes, Blimp-1, NFAT/AP-1), changes in metabolism, and a transcriptional program distinct from other T cell differentiation states. Ultimately, these signals lead to progressive loss of effector functions, altered homeostasis compared to T MEM , and cell death due to overstimulation. As a result, T cell exhaustion results in poor control of pathogens or tumors. However, the ability to partially reverse exhaustion through strategies including PD-1 pathway blockade suggests that T EX , or at least a subset of this pool, are not terminally differentiated and can contribute to protective immunity if re-invigorated.
Subsets of T EX
At least two subsets of T EX exist based on expression of PD-1 and the T-box transcription factors T-bet and Eomesodermin (Eomes) (Blackburn et al., 2008; Paley et al., 2012) . One subset expresses high T-bet and intermediate PD-1 (T-bet hi PD-1 int ), whereas the other subset expresses high Eomes and high PD-1 but lower T-bet (Eomes hi PD-1 hi ). These two subsets differ in key functions. The T-bet hi PD-1 int subset retains moderate proliferative capacity and some potential to produce effector cytokines (e.g., IFN, TNF) but has limited cytotoxicity. The Eomes hi PD-1 hi subset produces less cytokines and has poor proliferative potential but retains partial cytotoxicity compared to the T-bet hi PD-1 int subset . Only the T-bet hi PD-1 int subset can be reinvigorated by PD-1:PD-L1 pathway blockade, an observation with implications for immunotherapy (Blackburn et al., 2008) . A lineage relationship exists between these two subsets: the T-bet hi PD-1 int subset divides in response to persisting antigen, giving rise to Eomes hi PD-1 hi progeny. The Eomes hi PD-1 hi cells are terminally differentiated and do not convert back to T-bet hi PD-1 int cells . Thus, the T-bet hi PD-1 int cells are referred to as the "progenitor subset" and the Eomes hi PD-1 hi as the "terminal subset."
T EX Based on Anatomical Location
There is likely additional heterogeneity in the pool of T EX based on tissue location and disease context. In chronic infection, the T-bet hi progenitor subset is found in the spleen and blood, while the Eomes hi PD-1 hi terminal subset is more abundant in non-lymphoid tissues and possibly tumors. However, the distinct microenvironments of non-lymphoid tissues and tumors are likely to infl uence T EX biology. Indeed, different tissues have different ratios of T-bet hi to Eomes hi subsets, and T EX in these locations may differ in other key phenotypic and functional attributes (Blackburn et al., 2008; Paley et al., 2012) . Therefore, while T EX represents a discrete differentiation state compared to T N , T E , and T MEM , the disease context and location may impart additional layers of heterogeneity.
